Make sure your care provider is aware of your medical history and any other drugs you may be taking
For patients whose genetics or prior response suggest GIP pathway sensitivity, tirzepatide unlocks additional weight loss
The causes are firstly Coeliac disease, where there is flattened microvilli where DAO is located, so there is a reduced ability to breakdown histamine
Attributing the result to the shot is a reasoning error, not a finding
[DOI] [PMC free article] [PubMed] [Google Scholar] 194.Yang JC, Cortopassi GA
JAMA Network Another large observational study found that people with T2DM and obesity using semaglutide or tirzepatide had lower risk of dementia, stroke, and all-cause mortality compared to those on other glucoselowering agents